Sempra (NYSE:SRE) finished Friday with an addition of $0.78 to close at $71.56, an upside of 1.10 percent. An average of 2,072,660 shares of common stock have been traded in the last five days. There was a gain of $0.85 in the past week, and it reached a new high 7 times over the past 12 months. The last 20 days have seen an average of 2,336,585 shares traded, while the 50-day average volume stands at 2,202,618.
SRE stock has decreased by -4.18% in the last month. The company shares reached their 1-month lowest point of $69.88 on 08/16/23. With the stock rallying to its 52-week high on 01/17/23, shares of the company touched a low of $68.27 and a high of $88.24 in 52 weeks. It has reached a new high 6 times so far this year and lost -7.39% or -$5.71 in price. In spite of this, the price is down -18.90% from the 52-week high.
Insider Transactions
SRE stock investors should be aware that Sempra (SRE) stock had its last reported insider trading activity 164 days ago on Mar 15. In this transaction, the insider spent $2,813,736. Executive VP and CFO, MIHALIK TREVOR I, disposed of 2,306 shares at a price of $148.50 on Mar 01. The insider now owns more than $342,441 worth of shares. Prior to that, Chairman, CEO and President Martin Jeffrey W went on to Sale 10,413 shares at $150.99 each on Feb 28. An amount of $1,572,276 was transacted.
Valuation Metrics
Sempra (SRE) has a trailing price-to-earnings (P/E) ratio of 4.53. The stock’s beta is 0.75. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 2.66, the price-to-book (PB) ratio at 0.84.
The company has a payout ratio of 58.40%. The company’s most recent quarterly dividend payment was $0.5950 a share, without any change from last year. Its latest increase dividend $0.0225 reported on Tuesday February 28 2023.
Financial Health
The quick ratio of Sempra for the three months ended June 29 was 0.50, and the current ratio was 0.60, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 1.02 and a total debt to equity ratio of 1.15 for the quarter ending June 29. Sempra’s EBITDA margin for the year ending June 29 is 35.65%, while its operating margin for the same period stands at 19.20%. Its gross profit as reported stood at $2.3 billion compared to revenue of $14.44 billion.
Earnings Surprise
For the three-month period that ended June 29, Sempra had $27.52 billion in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $603.0 million in the quarter, while revenues were grew 7.3%. The analyst consensus anticipated Sempra’s latest quarter earnings to come in at $0.88 per share, but it turned out to be $0.94, a 6.80% surprise. For the quarter, EBITDA amounted to $1.34 billion. Shareholders own equity worth $314.65 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Sempra (SRE) price momentum. RSI 9-day as of the close on 25 August was 49.43%, suggesting the stock is Neutral, with historical volatility in this time frame at 16.76%.
As of today, SRE’s price is $71.32 +1.19% or $0.85 from its 5-day moving average. SRE is currently trading -4.14% lower than its 20-day SMA and -4.32% lower than its 100-day SMA. However, the stock’s current price level is -2.83% below the SMA50 and -4.40% below the SMA200.
The stochastic %K and %D were 43.30% and 40.25%, respectively, and the average true range (ATR) was 1.30. With the 14-day stochastic at 47.86% and the average true range at 1.29, the RSI (14) stands at 47.00%. The stock has reached 0.42 on the 9-day MACD Oscillator while the 14-day reading was at 0.16.
Analyst Ratings
Barclays launched coverage on Sempra (NYSE: SRE) in its analyst report released on August 23, 2023. The firm assigned the stock an Overweight rating. The consensus rating for Sempra (SRE) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell SRE, while 6 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 2 analysts, while 10 others rate it as a “buy”.
What is SRE’s price target for the next 12 months?
Analysts predict a range of price targets between $76.00 and $96.00, with a median target of $83.50. Taking a look at these predictions, the average price target given by analysts for Sempra (SRE) stock is $84.39.
